Newsroom

CHICAGO--(BUSINESS WIRE)--The Federal Home Loan Bank of Chicago (FHLBank Chicago) today released its 2025 Impact Report, highlighting another year of meaningful support for member financial institutions and communities across Illinois and Wisconsin. As housing affordability challenges persisted and economic conditions remained dynamic, FHLBank Chicago continued to provide the liquidity, funding, and community investment programs its over 600 members rely on to drive local impact. Through human...

QUANTICO, Va.--(BUSINESS WIRE)--Unveiled at Modern Day Marine 2026, Teledyne FLIR Defense announced the expansion of its Third-Party Payload Integration Program with the certification of Emesent’s Hovermap LiDAR Payload. The agreement will deliver Emesent’s GPS-denied 3D-mapping capabilities across Teledyne FLIR’s unmanned aerial systems (UAS), ground robots, and radiation detection platforms. The Emesent–Teledyne FLIR combination addresses a GPS-denial gap in air and ground domains where unman...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it will participate in the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026. Bernard Zovighian, chief executive officer, will participate in a fireside chat at 3:40 p.m. Pacific Time. A live webcast of the discussion will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com, with an archived version accessible later the same day. About Edwards Lifesciences...

MANCHESTER, Ga.--(BUSINESS WIRE)--Rare Earths Americas, Inc. (“REA” or the “Company”), a critical minerals company advancing a portfolio of prospective heavy rare earths focused projects in the United States and in Brazil, announced today the launch of its initial public offering of its common stock. The offering consists of approximately 2.8 million shares of common stock all of which are being offered by REA. In addition, REA intends to grant the underwriters a 30-day option to purchase up to...

CORNING, N.Y.--(BUSINESS WIRE)--Corning Incorporated (NYSE: GLW) today announced its first-quarter 2026 results and provided its outlook for second-quarter 2026. News Summary: First-quarter core sales grew 18% to $4.35 billion, and core EPS grew 30% to $0.70 versus Q1-2025. Robust demand for Gen AI products and the ramp of new solar products drove Q1 growth. Optical Communications sales grew 36%, and Solar sales were up 80% year over year. Two additional hyperscale customers entered into large,...

RICHARDSON, Texas--(BUSINESS WIRE)--ARGO, the leading provider of high-value technology and analytical-sciences software for the financial services and healthcare industries, has been named a finalist in the 2026 Banking Tech Awards USA in the category of “Best Customer Experience Solution” for its ARGO Connects platform. ARGO Connects is an all-in-one digital engagement platform designed to help financial institutions transform customer acquisition, fulfillment, service, and relationship growt...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that new preclinical data from its PBGENE-DMD program have been accepted for an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting, taking place May 11-15, 2026, in Boston, Massachusetts. The accepted abs...

NEW YORK--(BUSINESS WIRE)--Starboard Value LP (together with its affiliates, “Starboard”), one of the largest shareholders of Dynatrace, Inc. (“Dynatrace” or the “Company”) (NYSE: DT), today announced that it has delivered a letter to Dynatrace’s Chief Executive Officer, Rick McConnell, Chief Financial Officer, Jim Benson, and the Company’s Board of Directors. The full text of Starboard's letter to the Company can be viewed here. About Starboard Value LP Starboard Value LP is an investment advi...

PRINCETON, N.J. & TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Therapeutics, Inc. (Nasdaq: CGEM) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for zipalertinib for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins) mutations whose disease has progressed...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the BofA Securities 2026 Health Care Conference in Las Vegas on Wednesday, May 13, 2026 at 9:20 a.m. (Pacific Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insulet C...